Mega Genomics Limited

6667

KYG5960G1047

Healthcare Facilities & Services

Delayed Hong Kong S.E. Other stock markets 01:35:10 2024-04-19 am EDT			5-day change	1st Jan Change
8.85 ^HKD	-1.67%		-1.22%	-13.88%

Mar. 26	Mega Genomics Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 12	Mega Genomics Stockholders to Vote March 1 on Continuing Transactions	MT

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Mega Genomics Limited

Mega Genomics Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Mega Genomics Stockholders to Vote March 1 on Continuing Transactions	Feb. 12	MT
Mega Genomics Directors Terminate CEO	Jan. 17	MT
Mega Genomics Limited Announces Resignation of Huang Yufeng as an Executive Director	Jan. 17	CI
Mega Genomics Limited Announces Chief Executive Officer Changes	Jan. 17	CI
Mega Genomics Limited commences an Equity Buyback Plan for 23,923,380 shares, representing 10% of its issued share capital, under the authorization approved on June 9, 2023.	23-10-24	CI
Mega Genomics Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Mega Genomics Eyes Buyback of Nearly 24 Million Shares	23-07-24	MT
Mega Genomics Limited Announces Resignation of Li Yan as Joint Company Secretary	23-07-21	CI
Certain Ordinary Shares of Mega Genomics Limited are subject to a Lock-Up Agreement Ending on 22-JUN-2023.	23-06-21	CI
Mega Genomics Warns of 2022 Loss	23-03-21	MT
Mega Genomics Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022	23-03-20	CI
Certain Ordinary Shares of Mega Genomics Limited are subject to a Lock-Up Agreement Ending on 22-DEC-2022.	22-12-21	CI
Mega Genomics Limited Announces Change of Registered Office Address in the Cayman Islands	22-10-18	CI
Mega Genomics Completes Capital Reduction, Signs New Contracts	22-09-30	MT
Mega Genomics' H1 Profit Halves	22-09-27	MT
Mega Genomics Limited Change of Address of Principal Place of Business in Hong Kong	22-08-05	CI
Mega Genomics' Hong Kong IPO Stabilization Ends with No Overallotment	22-07-18	MT
Hong Kong Stocks Snap Three-Day Rally; Mega Genomics Wipes Out Early Gains in Debut	22-06-22	MT
Mega Genomics Defies Weak Sentiment for Hong Kong Debutants as Shares Rise 8% at Open	22-06-21	MT
Mega Genomics Limited has completed an IPO in the amount of HKD 215.3124 million.	22-06-21	CI
Mega Genomics Braves Market Turbulence, Raises $19.5 Million in Hong Kong IPO	22-06-20	MT
Mega Genomics Limited has filed an IPO in the amount of HKD 263.1596 million.	22-06-10	CI

Mega Genomics Ltd is a China-based investment holding company principally engaged in genetic testing business. The Company operates its businesses through three segments. The Consumer Genetic Testing Services segment provides testing for nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, pharmacogenetic testing and infectious disease testing. The Cancer Screening Services segment provides Septin9 colorectal cancer screening test, Syndecan-2 (SDC2) colorectal cancer screening test and ring finger protein 180 (RNF180)/Septin9 gastric cancer screening test. The Other Services segment provides genetic research and analysis services to third party research institutions.

Sector

Healthcare Facilities & Services

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
MEGA GENOMICS LIMITED	-13.88%	272M
SONIC HEALTHCARE LIMITED	-18.06%	8.02B
RADNET, INC.	+36.93%	3.51B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-26.72%	2.97B
SYNLAB AG	-7.36%	2.48B
DR. LAL PATHLABS LIMITED	-15.77%	2.23B
NEOGENOMICS, INC.	-14.89%	1.76B
FLEURY S.A.	-23.12%	1.44B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-39.19%	1.25B
ADICON HOLDINGS LIMITED	-10.74%	1.11B